U.S. Department of Health & Human Services
National Institutes of Health
NCATS
This repository is under review for potential modification in compliance with Administration directives.
Dismiss
Return Home
Inxight
Drugs
Search Substances
Home
Browse Drugs
US Approved Drugs
Marketed Drugs
Investigational Drugs
All Substances
Search
Structure Search
Sequence Search
Downloads
About
Search Substances
CAMRELIZUMAB
73096E137E
Investigational
General
Names
8
Classification
3
Identifiers
7
Subunits
4
Related Substances
1
CAMRELIZUMAB
73096E137E
Investigational
General
Approval Year
Unknown
149,124
Names
8
Show
5
20
100
All
entries
Name
Type
Language
Name
Type
Language
camrelizumab [INN]
Preferred Name
English
CAMRELIZUMAB
Official Name
English
Carilizumab
Common Name
English
Carrelizumab
Common Name
English
Camrelizumab [WHO-DD]
Common Name
English
Showing 1 to 5 of 8 entries
Previous
1
2
Next
Classification
3
Show
5
20
100
All
entries
Classification Tree
Code System
Code
Classification Tree
Code System
Code
Antineoplastic Biological Agent
Pharmacologic Substance
[C1909]
Biological Agent
[C307]
Antineoplastic Biological Agent
[C129821]
Antineoplastic Antibody
NCI_THESAURUS
C129822
Monoclonal Antibody
Pharmacologic Substance
[C1909]
Biological Agent
[C307]
Monoclonal Antibody
[C20401]
Anti-PD1 Monoclonal Antibody
NCI_THESAURUS
C128037
Designated
ORPHAN DRUG
Designated
Treatment of hepatocellular carcinoma
FDA ORPHAN DRUG
675718
Showing 1 to 3 of 3 entries
Previous
1
Next
Identifiers
7
Show
5
20
100
All
entries
Code System
Code
Type
Description
Code System
Code
Type
Description
SMS_ID
100000174636
PRIMARY
FDA UNII
73096E137E
PRIMARY
INN
10400
PRIMARY
CAS
1798286-48-2
PRIMARY
DRUG BANK
DB14776
PRIMARY
Showing 1 to 5 of 7 entries
Previous
1
2
Next
Subunits
4
Subunit 0
>SUBUNIT_0
Subunit 1
>SUBUNIT_1
Subunit 2
>SUBUNIT_2
Subunit 3
>SUBUNIT_3
Related Substances
1
ACTIVE MOIETY
73096E137E
CAMRELIZUMAB